Literature DB >> 17400699

Low-resolution structure and fluorescence anisotropy analysis of protein tyrosine phosphatase eta catalytic domain.

Huita C Matozo1, Maria A M Santos, Mario de Oliveira Neto, Lucas Bleicher, Luís Mauricio T R Lima, Rodolfo Iuliano, Alfredo Fusco, Igor Polikarpov.   

Abstract

The rat protein tyrosine phosphatase eta, rPTPeta, is a class I "classical" transmembrane RPTP, with an intracellular portion composed of a unique catalytic region. The rPTPeta and the human homolog DEP-1 are downregulated in rat and human neoplastic cells, respectively. However, the malignant phenotype is reverted after exogenous reconstitution of rPTPeta, suggesting that its function restoration could be an important tool for gene therapy of human cancers. Using small-angle x-ray scattering (SAXS) and biophysical techniques, we characterized the intracellular catalytic domain of rat protein tyrosine phosphatase eta (rPTPetaCD) in solution. The protein forms dimers in solution as confirmed by SAXS data analysis. The SAXS data also indicated that rPTPetaCD dimers are elongated and have an average radius of gyration of 2.65 nm and a D(max) of 8.5 nm. To further study the rPTPetaCD conformation in solution, we built rPTPetaCD homology models using as scaffolds the crystallographic structures of RPTPalpha-D1 and RPTPmicro-D1 dimers. These models were, then, superimposed onto ab initio low-resolution SAXS structures. The structural comparisons and sequence alignment analysis of the putative dimerization interfaces provide support to the notion that the rPTPetaCD dimer architecture is more closely related to the crystal structure of autoinhibitory RPTPalpha-D1 dimer than to the dimeric arrangement exemplified by RPTPmicro-D1. Finally, the characterization of rPTPetaCD by fluorescence anisotropy measurements demonstrates that the dimer dissociation is concentration dependent with a dissociation constant of 21.6 +/- 2.0 microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400699      PMCID: PMC1877755          DOI: 10.1529/biophysj.106.094961

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  49 in total

Review 1.  The catalytic mechanism of protein tyrosine phosphatases revisited.

Authors:  K Kolmodin; J Aqvist
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

Review 2.  Protein tyrosine phosphorylation in T cell signaling.

Authors:  Tomas Mustelin; Robert T Abraham; Christopher E Rudd; Andres Alonso; Joseph J Merlo
Journal:  Front Biosci       Date:  2002-04-01

Review 3.  Advances in structure analysis using small-angle scattering in solution.

Authors:  Dmitri I Svergun; Michel H J Koch
Journal:  Curr Opin Struct Biol       Date:  2002-10       Impact factor: 6.809

4.  The bZIP region of the plant transcription factor opaque-2 forms stable homodimers in solution and retains its helical structure upon subunit dissociation.

Authors:  Vitor Hugo Moreau; Alba C da Silva; Rodrigo M P Siloto; Ana Paula Valente; Adilson Leite; Fábio C L Almeida
Journal:  Biochemistry       Date:  2004-04-27       Impact factor: 3.162

5.  The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.

Authors:  T Florio; S Arena; S Thellung; R Iuliano; A Corsaro; A Massa; A Pattarozzi; A Bajetto; F Trapasso; A Fusco; G Schettini
Journal:  Mol Endocrinol       Date:  2001-10

6.  Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface.

Authors:  G Jiang; J den Hertog; T Hunter
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 7.  Protein-tyrosine phosphatases in development.

Authors:  J den Hertog
Journal:  Mech Dev       Date:  1999-07       Impact factor: 1.882

8.  An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.

Authors:  Rodolfo Iuliano; Francesco Trapasso; Ilaria Le Pera; Filippo Schepis; Irene Samà; Alessandra Clodomiro; Kristoffel R Dumon; Massimo Santoro; Lorenzo Chiariotti; Giuseppe Viglietto; Alfredo Fusco
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

9.  LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.

Authors:  Claudia Ruivenkamp; Mario Hermsen; Cindy Postma; Anita Klous; Jan Baak; Gerrit Meijer; Peter Demant
Journal:  Oncogene       Date:  2003-05-29       Impact factor: 9.867

10.  Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.

Authors:  Claudia A L Ruivenkamp; Tom van Wezel; Carlo Zanon; Alphons P M Stassen; Cestmir Vlcek; Tamás Csikós; Anita M Klous; Nikos Tripodis; Anastassis Perrakis; Lucie Boerrigter; Peter C Groot; Jan Lindeman; Wolter J Mooi; Gerrit A Meijjer; Gert Scholten; Hans Dauwerse; Vaclav Paces; Nico van Zandwijk; Gert Jan B van Ommen; Peter Demant
Journal:  Nat Genet       Date:  2002-06-24       Impact factor: 38.330

View more
  3 in total

1.  Reactive oxygen species and epidermal growth factor are antagonistic cues controlling SHP-2 dimerization.

Authors:  Aurelio Pio Nardozza; Melania D'Orazio; Riccardo Trapannone; Salvatore Corallino; Giuseppe Filomeni; Marco Tartaglia; Andrea Battistoni; Gianni Cesareni; Luisa Castagnoli
Journal:  Mol Cell Biol       Date:  2012-03-12       Impact factor: 4.272

2.  Dissecting the Relation between a nuclear receptor and GATA: binding affinity studies of thyroid hormone receptor and GATA2 on TSHβ promoter.

Authors:  Ana Carolina Migliorini Figueira; Igor Polikarpov; Dmitry Veprintsev; Guilherme Martins Santos
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

3.  Preparation and characterization of PEGylated amylin.

Authors:  Luiz Henrique Guerreiro; Mariana F A N Guterres; Bruno Melo-Ferreira; Luiza C S Erthal; Marcela da Silva Rosa; Daniela Lourenço; Priscilla Tinoco; Luís Maurício T R Lima
Journal:  AAPS PharmSciTech       Date:  2013-07-02       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.